Results 11 to 20 of about 2,883,949 (197)

Comparative analysis of presence of Cytomegalovirus (CMV) and Epsteinbarr virus -1 (EBV-1) in cases of chronic periodontitis and aggressive periodontitis with controls

open access: yesIndian Journal of Dental Research, 2012
Aim : The aim of the present study was to evaluate the presence of Cytomegalovirus (CMV) and Epsteinbarr virus -1 (EBV-1)viruses in sub gingival plaque of chronic periodontitis (groupA), aggressive periodontitis patients (group B), periodontally healthy ...
Rupali Sharma   +5 more
doaj   +4 more sources

Full Recovery from Chronic Fatigue Caused by Reactivation of the EpsteinBarr Virus Through the Use of Basic Micronutrition and Specific Micronutrition

open access: yesOpen Access Journal of Pharmaceutical Sciences and Drugs
Background and objective: Chronic fatigue syndrome (CFS) is a disorder whose main symptom is tiredness that fails to improve with rest and worsens with exercise. It is a complex and chronic disorder of unknown etiology with general, physical and neurophysical manifestations. There are numerous theories regarding its etiology.
Flores Montero Natalia
exaly   +3 more sources

The role of Epstein-Barr virus in systemic lupus erythematosus [PDF]

open access: yesMedicinski Podmladak, 2023
Systemic lupus erythematosus (SLE) is a systemic autoimmune inflammatory disease that develops in a complex interaction of genetic and environmental factors.
Mišković Rada   +2 more
doaj   +2 more sources

THE EFFECTIVENESS OF DIFFERENT REGIMENS OF THERAPY IN PATIENTS WITH CHRONIC FORMS OF EPSTEINBARR VIRUS INFECTION

open access: yesBulletin of Problems Biology and Medicine, 2018
T. I. Liadova   +3 more
exaly   +3 more sources

Efficacy and safety of tabelecleucel in patients with EpsteinBarr Virus-associated leiomyosarcomas (EBV+ LMS) [PDF]

open access: yesAnnals of Oncology, 2018
34O. ESMO Immuno-Oncology December 15, 2018 • I have no personal disclosures. • Atara Biotherapeutics holds the license and IND to develop and commercialize the third party EBV cell therapy program (Tabelecleucel) I will be discussing today.
L.S. Kurlander   +16 more
openaire   +2 more sources

Is previous infection by EpsteinBarr Virus (EBV) or Cytomegalovirus (CMV) a considerable risk factor for the development of Multiple Sclerosis (MS) in adults?

open access: yesSão Paulo Medical Journal, 2021
Background and objective: Multiple Sclerosis (MS) is a neurodegenerative, inflammatory and demyelinating disease of the central nervous system. The mechanisms that cause MS are still unknown. However, many variables appear as possible risk factors for the development of this disease.
Leonardo Mattos Santos   +8 more
openaire   +2 more sources

The incidence of infection in tumor and eye fluid system, and specific humoral immunity to herpes viruses in patients with uveal melanoma

open access: yesВопросы вирусологии, 2023
Introduction. Studies aimed at a direct research of human herpes viruses (HHVs) in the tumor material and eye media have not been carried out so far. Research goal to establish the frequency of detection HHVs DNA in the biomaterial of the eye and ...
E. V. Svetlova   +7 more
doaj   +2 more sources

Meningo encephalitis with Epstein-Barr virus in an immunocompetent adult patient: case report [PDF]

open access: yesRomanian Journal of Infectious Diseases, 2023
Epstein-Barr virus is a rare ethology of the neurological infections, expressed as encephalitis, aseptic meningitis, Guillain-Barre syndrome or acute demyelinating encephalomyelitis.
Sabina-Lucia Ganea   +4 more
doaj   +1 more source

Etiological factors of voiding disorders in females [PDF]

open access: yesConsilium Medicum, 2022
Background. Voiding disorders in females are a serious medical and social problem. Various urological, gynecological, and neurological factors contribute to the development of these disorders. Aim.
Inga V. Kosova   +7 more
doaj   +1 more source

Rapid Onset Severe Immune Thrombocytopenia following mRNA COVID‐19 Vaccine in a Young Patient

open access: yesCase Reports in Hematology, Volume 2023, Issue 1, 2023., 2023
The coronavirus disease 2019 (COVID‐19) pandemic has affected millions of people around the world. Vaccination against COVID‐19 has been approved for the following three vaccines in the United States: Pfizer‐BioNTech, Moderna, and Janssen. Hematological complications of vaccination have been reported in the literature but remain as a rare phenomenon ...
Jorge Avila   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy